pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,939 catalysts · 5,063 phase readout · 2,308 8k filing · 316 pdufa · 271 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,063
  • 8k filing2,308
  • pdufa316
  • earnings271
  • phase 2 completion108
  • phase 1 completion50
  • phase 1 2 completion28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area
    • Oncology87
    • Cardiology23
    • Immunology15
    • Infectious Disease12
    • Dermatology12
    • Ophthalmology8
    • Women's Health8
    • Pulmonology8
    • Pain6

    Date TBD

    50
    ›COMPLETEDphase readoutNCT04228627: Ferritin Screening And IRon Treatment for Maternal Anemia and FGR Prevention Trial

    Sponsor: Services Institute of Medical Sciences, Pakistan. Phase: PHASE4. Conditions: Iron Deficiency (Without Anemia), Pregnancy Related

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06928727: Ocular Characteristics in Patients With Craniosynostosis

    Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: . Conditions: Craniosynostosis, Strabismus, Intracranial Hypertension, Amblyopia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07398742: Incidence and Microbial Profiles of Periprosthetic Joint Infection After Total Knee Arthroplasty in Obese vs Non-Obese Patients

    Sponsor: Bispebjerg Hospital. Phase: . Conditions: Knee Arthropathy, PJI

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06990750: Single Port Insufflation RCT

    Sponsor: University of Chicago. Phase: NA. Conditions: Postoperative Pain Score

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06891950: Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)

    Sponsor: Butantan Institute. Phase: PHASE3. Conditions: Dengue

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07206550: The Role of Framing and Choice Architecture in Patients' Reactions and EHR Error Discovery and Reporting

    Sponsor: The University of Texas at Dallas. Phase: NA. Conditions: Electronic Health Records

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07251491: Psilocybin to Treat Depression in Spinal Cord Injury

    Sponsor: James J. Peters Veterans Affairs Medical Center. Phase: PHASE1. Conditions: Spinal Cord Injury, Depression - Major Depressive Disorder, Veteran

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07491718: Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy

    Sponsor: University of Edinburgh. Phase: NA. Conditions: Takotsubo Cardiomyopathy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07359118: Assessment of Healthcare Professionals' Knowledge and Attitudes Toward Patient-Controlled Analgesia

    Sponsor: Kutahya Health Sciences University. Phase: NA. Conditions: Postoperative Pain Management

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07496190: Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy

    Sponsor: Sun Yat-sen University. Phase: PHASE2. Conditions: Nasopharyngeal Cancinoma (NPC)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05210413: Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults

    Sponsor: University Hospital, Bordeaux. Phase: PHASE1. Conditions: Refractory or Recurrent Solid Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06727513: A Two-Operator Technique for GlideScope-Assisted Endotracheal Intubation

    Sponsor: American University of Beirut Medical Center. Phase: NA. Conditions: Intubation; Difficult or Failed, Intubation Complication, Airway Trauma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07039760: Asciminib With or Without Sildenafil for Brain Tumors

    Sponsor: Washington University School of Medicine. Phase: EARLY_PHASE1. Conditions: Brain Tumor

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07148024: Cuff Pressure and Airway Edema in CABG With CPB

    Sponsor: Engin Çetin. Phase: NA. Conditions: Airway Ultrasound, Airway Edema, Endotracheal Tube

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04242823: Primary HPV-based Cervical Cancer Screening Algorithms in Botswana

    Sponsor: Beth Israel Deaconess Medical Center. Phase: NA. Conditions: Cervical Cancer, Prevention

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00001823: Evaluation for NCI Surgery Branch Clinical Research Protocols

    Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Synovial Cell Cancer, Melanoma, Colorectal Cancer, Lung Cancer, Bladder Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05064280: Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Brain Metastases, Tumor

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04982796: Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder

    Sponsor: Portland VA Research Foundation, Inc. Phase: PHASE1. Conditions: Amphetamine-Related Disorders

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05609188: Black Economic Equity Movement

    Sponsor: University of California, San Francisco. Phase: NA. Conditions: Mental Health Wellness 1, Health Care Utilization, Financial Hardship, Education, Professional

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07214688: Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

    Sponsor: Hackensack Meridian Health. Phase: PHASE2. Conditions: Allogeneic Stem Cell Transplant Recipient

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07294703: Factors Associated With Breast Cancer Risks and Outcomes

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07264361: Evaluation of the Safety and Efficacy of the D.D.C Dual-control Technology Spectacle Lenses in Delaying the Progression of Myopia: a Randomized Controlled Trial

    Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University. Phase: NA. Conditions: Myopia, Progressive

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04943861: Human Immunodeficiency Virus (HIV) Food Insecurities

    Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Food Insecurities, Cardiometabolic Comorbidities, HIV, PreDiabetes, Type 2 Diabetes Mellitus (T2DM)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05366361: The Dynamics of Human Atrial Fibrillation

    Sponsor: Stanford University. Phase: . Conditions: Atrial Fibrillation, Arrhythmias, Cardiac

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07414797: Discomfort Following Oral Biopsy Comparing Laser and Punch Biopsy

    Sponsor: Catholic University of the Sacred Heart. Phase: NA. Conditions: Oral Lichen Planus, Biopsy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06126497: Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients

    Sponsor: Suven Life Sciences Limited. Phase: PHASE2. Conditions: Major Depressive Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07505810: Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months

    Sponsor: Sinovac Biotech Co., Ltd. Phase: PHASE3. Conditions: Epidemic Meningitis, Meningococcal Vaccines

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07276360: Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda

    Sponsor: Uganda Cancer Institute. Phase: PHASE2. Conditions: Cervical Cancer, Cervix Cancer, Cervical Adenocarcinoma, Cervical Small Cell Carcinoma, Cervical Adenosquamous Carcinoma

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT05512260: Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs

    Sponsor: Karolinska Institutet. Phase: NA. Conditions: Neoplasm, Colorectal, Neoplasm, Breast, Neoplasm, Ovarian

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05341960: Nourishing Beginnings: Addressing Food Insecurity During Pregnancy

    Sponsor: Case Western Reserve University. Phase: NA. Conditions: Pregnancy Related, Food Insecurity, Premature Birth, Pregnancy Complications

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07520682: Orthognathic Surgery in Anterior Open Bite: a Retrospective Study of 50 Patients With Initial Tongue Malposition

    Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Patients With Anterior Open Bite Malocclusion and Who Benefited of an Orthognathic Surgery, Infantile Swallowing and Tongue Malposition Necessitating Tongue Rehabilitation

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04438382: Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

    Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE2. Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Steroid-Refractory Pneumonitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07111559: Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial

    Sponsor: Nippon Medical School. Phase: PHASE4. Conditions: Lacunar Stroke, Stroke, Ischemic Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07306559: A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

    Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Advanced Relapsed or Refractory Germ Cell Tumours, Advanced Relapsed or Refractory Endometrial Cancer, Advanced Relapsed or Refractory Ovarian Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07458659: Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

    Sponsor: Chulalongkorn University. Phase: EARLY_PHASE1. Conditions: Relapsed/Refractory Multiple Myeloma (MM)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07265479: A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

    Sponsor: Organon and Co. Phase: PHASE3. Conditions: Atopic Dermatitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06161662: STimulation Electronically of Acupoints for Postoperative Delirium in elderlY Patients

    Sponsor: Zhihong LU. Phase: NA. Conditions: Anesthesia, Postoperative Delirium, Electroencephalogram

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06014762: P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

    Sponsor: Poseida Therapeutics, Inc.. Phase: PHASE1. Conditions: Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, High-grade B-cell Lymphoma, Primary Mediastinal Large B-cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (tFL), Follicular Lymphoma Grade 3B, DLBCL, DLBCL - Diffuse Large B Cell Lymphoma, DLBCL Arising From Follicular Lymphoma, DLBCL, Diffused Large B Cell Lymphoma, DLBCL NOS

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT03065062: Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors

    Sponsor: Dana-Farber Cancer Institute. Phase: PHASE1. Conditions: Lung Cancer Squamous Cell, Solid Tumors, Head & Neck Cancer, Pancreatic Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06414603: A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy

    Sponsor: Natera, Inc.. Phase: NA. Conditions: Heart Transplant Failure and Rejection

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05206227: Histamine as a Molecular Transducer of Adaptation to Exercise

    Sponsor: University of Oregon. Phase: EARLY_PHASE1. Conditions: Postexercise Hypotension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07314073: [18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer

    Sponsor: Asan Medical Center. Phase: PHASE2. Conditions: Stage III Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05229341: Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules

    Sponsor: City of Hope Medical Center. Phase: NA. Conditions: Thyroid Gland Carcinoma

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06871683: ClotTriever® Thrombectomy System Use-Result Survey in Japan

    Sponsor: Inari Medical. Phase: . Conditions: Deep Vein Thrombosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT00378105: Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma

    Sponsor: Dana-Farber Cancer Institute. Phase: PHASE1. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03308305: Cracking Coma: Towards EEG and MRI Based Precision Medicine After Cardiac Arrest

    Sponsor: Rijnstate Hospital. Phase: . Conditions: Post-Anoxic Coma, Postanoxic Enchephalopathie

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06594094: An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE)

    Sponsor: HuidaGene Therapeutics Co., Ltd.. Phase: EARLY_PHASE1. Conditions: Duchenne Muscular Dystrophin (DMD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07492966: Exosomes Effect on Visual Function in CVI

    Sponsor: Hatice Semrin Timlioglu İper. Phase: . Conditions: Cortical Visual Impairment, Visual Function

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06901466: STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant

    Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital. Phase: PHASE4. Conditions: Mitral Regurgitation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07323966: Feasibility of Mask-Free Radiotherapy for Brain Tumor Patients

    Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Phase: NA. Conditions: Brain Tumor

    full page →ctgov ↗
    ← prev
    page 72 of 159
    next →